Dietary Approaches for Management of Non-Alcoholic Fatty Liver Disease: A Clinician's Guide - PubMed (original) (raw)

Review

Dietary Approaches for Management of Non-Alcoholic Fatty Liver Disease: A Clinician's Guide

Aiya Aboubakr et al. Curr Gastroenterol Rep. 2021.

Abstract

Non-alcoholic fatty liver disease (NAFLD) is closely associated with obesity, insulin resistance, and hyperlipidemia. There is strong clinical evidence that reduction in at least 5-7% total body weight is associated with improvement in hepatic steatosis and regression of fibrosis, with weight loss representing the primary approach to treatment. This guide reviews recent data on dietary approaches studied in NAFLD management. The strongest evidence currently supports a hypocaloric diet to induce weight loss and subsequent improvement in liver enzymes and histology, as well as a Mediterranean diet, which can lead to improvement in steatosis even in the absence of weight reduction. The purpose of this paper is to provide clinicians with tools to engage patients in conversations about nutrition in the setting of NAFLD, ultimately guiding suitable personalized dietary recommendations.

Keywords: Diet; Hepatic steatosis; Non-alcoholic fatty liver disease (NAFLD); Obesity; Weight loss.

© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

PubMed Disclaimer

References

Papers of particular interest, published recently, have been highlighted as: •• Of major importance
    1. •• Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328–57. https://doi.org/10.1002/hep.29367 . Updated American hepatology practice guidelines on management of NAFLD including recommendation to pursue weight loss through hypocaloric diet. - DOI - PubMed
    1. Younossi Z, Tacke F, Arrese M, et al. Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Hepatology. 2019;69(6):2672–82. https://doi.org/10.1002/hep.30251 . - DOI - PubMed
    1. Romero-Gómez M, Zelber-Sagi S, Trenell M. Treatment of NAFLD with diet, physical activity and exercise. J Hepatol. 2017;67(4):829–46. https://doi.org/10.1016/j.jhep.2017.05.016 . - DOI - PubMed
    1. Musso G, Cassader M, Rosina F, Gambino R. Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials. Diabetologia. 2012;55(4):885–904. https://doi.org/10.1007/s00125-011-2446-4 . - DOI - PubMed
    1. Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, et al. Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis. Gastroenterology. 2015;149(2):367-78.e5. https://doi.org/10.1053/j.gastro.2015.04.005 . quiz e14-5. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources